Loading clinical trials...
Loading clinical trials...
Phase I-II Study of Weekly CPT-11 and Radiation Therapy for Unresectable or Locally Recurrent Large Bowel Cancer
Conditions
Interventions
irinotecan hydrochloride
radiation therapy
Locations
1
United States
Medical University of South Carolina
Charleston, South Carolina, United States
Start Date
August 1, 1998
Primary Completion Date
January 1, 2000
Completion Date
January 1, 2000
Last Updated
May 16, 2018
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
Medical University of South Carolina
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions